Following the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, LBCA sat down with Dr. Julie Sutcliffe, Professor at the University of California, […]
New Imaging Research Offers Hope for Detecting and Treating Lobular Breast Cancer Read More »
Dr. Shannon Klingman, founder of Lume Deodorant, was inspired to help fund lobular breast cancer research after her own diagnosis with invasive lobular carcinoma (ILC)
In February, LBCA sponsored a guest lectureship by LBCA and Sarah Bieze ILC research grantee Dr. Manisha Bahl of Mass General Brigham. Dr. Bahl described
Lobular Breast Cancer Alliance Executive Director, Laurie Hutcheson, recently interviewed Scientific Advisory Board member Dr. Megan Kruse about her new role at Cleveland Clinic as
This second webinar, in a four-part series on liquid biopsy and ILC, brings together a unique panel including surgical and medical oncologists and a patient
The 2nd session in LBCA’s Liquid Biopsy Webinar Series Available To View On Demand Read More »
LBCA invites you to view the recording of the first session of a four part series on liquid biopsy/CtDNA tests and relevance for ILC. In this
Liquid Biopsy Webinar Series – View Session 1 On-Demand Read More »
Recently LBCA SAB member, Dr. Rita Mukhtar, Professor of Clinical Surgery at the University of California San Francisco was interviewed by LBCA Executive Director, Laurie
The Therapeutic Challenges of Lobular Breast Cancer – Interview with Dr. Rita Mukhtar Read More »
As part of the October 15th Global Lobular Breast Cancer Awareness Day in 2025, LBCA Patient Advocates discussed living with Metastatic Lobular Breast Cancer (mILC) to
Living with Metastatic ILC – A Conversation with Patient Advocates Read More »
October is Breast Cancer Awareness month and we continue to shine a spotlight on the 15% of breast cancer diagnosis that are invasive lobular carcinoma
Shining a Spotlight on Lobular Breast Cancer: Spread the Word Read More »
LBCA Executive Director Laurie Hutcheson spoke with Claire Turner, founder of Lobular Breast Cancer UK, to learn about the latest ILC advocacy efforts in the
An Update from the UK, Interview with Lobular Breast Cancer UK’s Claire Turner Read More »
LBCA Executive Director, Laurie Hutcheson, recently interviewed Dr. Julia Foldi about the results of her latest study, Personalized Circulating Tumor DNA Testing for Detection of
Lobular Research Chat with Dr. Julia Foldi Read More »
LBCA COO, Mason Mitchell-Daniels recently interviewed SAB Member, Dr. Rita Mukhtar about her latest ILC research, “Accuracy of Breast MRI for Surgical Planning After Neoadjuvant
LBCA SAB Member Dr. Rita Mukhtar Discusses New ILC Research Read More »
LBCA Executive Director, Laurie Hutcheson recently interviewed our newest Scientific Advisory Board (SAB) member, Dr. Anita Mamtani, to talk about her work in breast cancer
LBCA is grateful to introduce Jo Lynn Collins, who has agreed to serve as the new Metastatic ILC Patient Advocate Representative on the Patient Advocate
New Metastatic ILC Patient Advocate Representative on the PAAB Read More »
https://youtu.be/B9sPfZipwu8 The $100,000 SNMMI / LBCA Invasive Lobular Carcinoma Imaging Research Fellowship for the 2025 Mars Shot Fund was recently awarded to Randy Yeh, MD,
Lobular Breast Cancer Chat with Dr. Randy Yeh SNMMI LBCA ILC Research Grant Winner Read More »
"*" indicates required fields